Invivyd (IVVD) Times Interest Earned (2021 - 2025)
Invivyd (IVVD) posted Times Interest Earned of $39.86 for Q4 2025, up 397.58% on a QoQ basis from -$13.39 in Q3 2025, and up 45.92% year-over-year from $27.31 in Q4 2024.
Invivyd (IVVD) Times Interest Earned (2021 - 2025) Analysis & Trends
Invivyd's Times Interest Earned history runs 5 years deep, the most recent figure standing at $39.86 for Q4 2025.
- Quarterly Times Interest Earned rose 45.92% year-over-year to $39.86 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.05 (down 77.42% YoY) and the FY2025 annual result came in at -$0.22, up 69.56% from the prior year.
- Times Interest Earned was $39.86 for Q4 2025 at Invivyd, up from -$13.39 in the prior quarter.
- Across five years, Times Interest Earned topped out at $154.74 in Q4 2023 and bottomed at -$415.45 in Q4 2021.
- A 5-year average of -$72.3 and a median of -$17.58 in 2023 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2022 — Times Interest Earned plunged 7395.61% — and 2023, when it jumped 164.19%.
- Invivyd's Times Interest Earned stood at -$415.45 in 2021, then surged by 41.98% to -$241.06 in 2022, then soared by 164.19% to $154.74 in 2023, then sank by 82.35% to $27.31 in 2024, then surged by 45.92% to $39.86 in 2025.
- Business Quant data shows IVVD's Times Interest Earned at $39.86 in Q4 2025, -$13.39 in Q3 2025, and -$41.83 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 39.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.86 |
| Sep 30, 2025 | -13.39 |
| Jun 30, 2025 | -41.83 |
| Mar 31, 2025 | -84.61 |
| Dec 31, 2024 | 27.31 |
| Sep 30, 2024 | -143.24 |
| Jun 30, 2024 | -113.21 |
| Mar 31, 2024 | -1.39 |
| Dec 31, 2023 | 154.74 |
| Sep 30, 2023 | -21.76 |
| Jun 30, 2023 | -124.71 |
| Mar 31, 2023 | -54.88 |
| Dec 31, 2022 | -241.06 |
| Sep 30, 2022 | -7.72 |
| Jun 30, 2022 | -7.42 |
| Mar 31, 2022 | -9.51 |
| Dec 31, 2021 | -415.45 |
| Sep 30, 2021 | -0.10 |
| Jun 30, 2021 | -0.58 |
| Mar 31, 2021 | -387.09 |